But with Novartis failing to convince European regulators about the merits of Xiidra last year, and Allergan's ... a phase 3 trial for eye drops containing tivanisiran, in dry eye disease associat ...
The spokesperson added: “Allergan wants its patents to be enforced against infringers, (makers of generic eye drops) but in federal court, not in the IPR proceedings.” The tribe runs a large ...
Ocular surface discomfort can be problematic after cataract surgery. Italian researchers tested the use of cyclosporine A 0.1 ...
Michelle Hessen, OD, spoke about the results of a new study evaluating the efficacy of cyclosporine ophthalmic solution 0.09% in patients with dry eye.
Struggling with dry eyes and ready to seek professional help? Preparing for your visit to a dry eye doctor can make all the difference in diagnosing and treating your condition ...
In the study published in The BMJ, scientists proposed that laughter exercises could be a promising home-based solution for ...
A study by AIIMS reveals that bio-enhanced curcumin, found in turmeric (haldi), effectively treats mild to moderate dry eye ...
AbbVie today announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the efficacy and safety of ELAHERE® (mirvetuximab soravtansine-gynx) in women with folate receptor alpha ...
Silver began to weaken further on Monday following the establishment of a lower swing high last week at $32.77. Potential support around the 20-Day MA at $32.19 failed to hold as support on Monday ...
Continuous Glucose Monitor Data Predicts Type 1 Diabetes Complications Jan. 15, 2025 — Data from continuous glucose monitors can predict nerve, eye and kidney damage caused by type 1 diabetes ...
I’ve said this before: I’m no eye-cream evangelist ... This can be a deciding factor if you have an oily or dry skin type, where you might be looking for something that won’t feel heavy ...
If your skin is dry, too — or you’re just trying to manage seasonal dryness — I’m here to help you navigate the body-wash aisle. I tested several formulas myself and interviewed ...